Partner Content Partner Content Prescient Announces Recent Appointments to the Senior Adviso... Prescient hires two new senior members to Advisory Team
Partner Content Partner Content Prescient hires senior members to Advisory PRESCIENT ADVISORY ANNOUNCES RECENT APPOINTMENTS
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
